About Our Company
Girish Kulkarni is the President of Arborsense, Inc. He has over 8 years of experience working on carbon nanomaterials for applications in chemical and biochemical sensing. He received his B.Eng. in Electronics and Electrical Communications from Punjab Engineering College, India, and his M.S. and Ph.D. in Electrical Engineering from University of Michigan Ann Arbor. His work on nanobiosensors has has been widely reported in reputed forums like IEEE spectrum, Nanowerk, Wearable Tech, Health and Environment, Phys.org, Science Journal, etc.
Zhaohui Zhong is currently an Associate Professor of Electrical Engineering and Computer Science at the University of Michigan. He received his B.S. and M.S. in Chemistry from Nanjing University in 1998 and 2000, and his Ph.D. in Chemistry from Harvard University in 2005. His research lies at the frontiers of nanoelectronics and nanophotonics. He is a recipient of NSF CAREER award, serves as associate editor for IEEE Transaction of Nanotechnology and for Nano-micro Letters, and is a co-founder for Arborsense Inc. and Graphene Vision LLC.
Xudong Fan is a Professor at Biomedical Engineering Department at the University of Michigan. He has over 15 years of experience in biochemical sensor development and has worked extensively on micro-gas chromatography, optical biosensors, chemical sensors, optofluidics, microfluidic lasers, and nanoparticle synthesis. Xudong Fan received his B.S. and M.S. in Physics from Peking University in 1994, and his Ph.D. in Physics from Oregon State University in 2000. From 2000-2004, he was a Senior Research Scientist at 3M Corporation. He has co-founded two companies, Optofluidic BioAssay LLC and Arborsense Inc.
Other Team Members:
Mark Ilgen, PhD, is a clinical psychologist, an investigator with the VA Center for Clinical Management Research in Ann Arbor, Michigan and an Associate Professor in the Department of Psychiatry at the University of Michigan. He received his doctorate in clinical psychology from the University of Colorado, Boulder, and completed his clinical internship and postdoctoral fellowship at the Palo Alto VA. His work focuses on methods to improve treatment outcomes in patients with substance use disorders and/or chronic pain. Dr. Ilgen is also interested in evaluating strategies for decreasing the risk of suicide in individuals with alcohol or drug problems. His work is supported by the Department of Veterans Affairs, the Department of Defense and the National Institutes of Health.